1078 related articles for article (PubMed ID: 27825371)
1. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
Scarpignato C; Gatta L; Zullo A; Blandizzi C; ;
BMC Med; 2016 Nov; 14(1):179. PubMed ID: 27825371
[TBL] [Abstract][Full Text] [Related]
2. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
Targownik LE; Fisher DA; Saini SD
Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
[TBL] [Abstract][Full Text] [Related]
4. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
5. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
[TBL] [Abstract][Full Text] [Related]
6. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
Dharmarajan TS
J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors: use and misuse in the clinical setting.
Savarino V; Marabotto E; Zentilin P; Furnari M; Bodini G; De Maria C; Pellegatta G; Coppo C; Savarino E
Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1123-1134. PubMed ID: 30295105
[TBL] [Abstract][Full Text] [Related]
8. Deprescribing versus continuation of chronic proton pump inhibitor use in adults.
Boghossian TA; Rashid FJ; Thompson W; Welch V; Moayyedi P; Rojas-Fernandez C; Pottie K; Farrell B
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011969. PubMed ID: 28301676
[TBL] [Abstract][Full Text] [Related]
9. The appropriate use of proton-pump inhibitors.
Savarino V; Marabotto E; Zentilin P; Furnari M; Bodini G; De Maria C; Pellegatta G; Coppo C; Savarino E
Minerva Med; 2018 Oct; 109(5):386-399. PubMed ID: 29856192
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
[TBL] [Abstract][Full Text] [Related]
13. The use of proton pump inhibitors in children: a comprehensive review.
Gibbons TE; Gold BD
Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
[TBL] [Abstract][Full Text] [Related]
14. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
Lee L; Ramos-Alvarez I; Ito T; Jensen RT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623145
[TBL] [Abstract][Full Text] [Related]
15. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
Rababa M; Rababa'h A
BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
[TBL] [Abstract][Full Text] [Related]
16. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
Song H; Zhu J; Lu D
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010623. PubMed ID: 25464111
[TBL] [Abstract][Full Text] [Related]
17. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
Savarino V; Dulbecco P; de Bortoli N; Ottonello A; Savarino E
Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
[TBL] [Abstract][Full Text] [Related]
18. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]